|
Volumn 16, Issue 4, 2012, Pages
|
Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CASE CONTROL STUDY;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
DRUG COST;
ECONOMICS;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
METHODOLOGY;
NAUSEA;
NURSE ATTITUDE;
NURSE PATIENT RELATIONSHIP;
NURSING;
NURSING DIAGNOSIS;
ONCOLOGY NURSING;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
VOMITING;
ANTIEMETICS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CASE-CONTROL STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG COSTS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
NAUSEA;
NURSE'S ROLE;
NURSE-PATIENT RELATIONS;
NURSING DIAGNOSIS;
ONCOLOGIC NURSING;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
VOMITING;
MLCS;
MLOWN;
|
EID: 84871762658
PISSN: None
EISSN: 1538067X
Source Type: Journal
DOI: 10.1188/12.cjon.e133-e141 Document Type: Review |
Times cited : (37)
|
References (0)
|